Home | Survey | Payment| Talks & Presentations | Job Opportunities
Journals   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Chinese Journal of Pharmacovigilance
1672-8629
2013 Issue 9
Using HPLC to Determine Adenosine in Cordyceps Mortierella Mycelia Capsules
WU Wen;LIU Xiao-hong;ZHU Man-fang
..............page:540-542
an huang bi li pian zhi yao zhen 1 li
zhou qiu juan ; wu xiao yan ; zuo fa lin
..............page:575-576
France and Canada Drug Regulatory Agencies and Implication
ZHANG Hao;DONG Duo;CHENG Gang
..............page:536-539,542
Analysis of 37 Cases of Adverse Drug Reaction Reports by Metformin
SHI Hong-bo;CAI Qiang
..............page:563-566
zhu she yong 12 zhong fu he wei sheng su zhi guo min xing xiu ke 1 li
lu xiang hong ; yi dan ; li hui
..............page:576
Inspiration from EudraVigilance Access Policy for Medicines for Human Use
LIU Wei;DU Xiao-xi;SHEN Lu
..............page:533-535
Post-marketing Safety Literature Analysis and Risk Control Recommendations of Shuxuening Injection
YANG Le;WANG Yan-chun;DU Xiao-xi;REN Jing-tian;Song Hai-bo;LIU Xi-dan
..............page:553-556
Analysis of Blood Concentrations of Sodium Valproate in 248 Cases of Perioperative Patients with Brain Tumors
LI Zheng-ran;ZHU Yue-ting;GAO Chen;HUANG Jia;LI Ji-yang;CUI Xiang-li
..............page:520-522
Literature Analysis of 97 Cases of Adverse Drug Reaction Induced by Fosfomycin Sodium
TANG Ren;GAO Yan;FAN Yan
..............page:560-562,566
Literature Analysis of 241 Cases of Adverse Drug Reactions Induced by Lincomycin
CHEN Xing-Li;LIAN Shi-tao;DU-Yan;HAN Da-bin;CHENG Xiao-ping
..............page:557-559
A Method for Quantitative Determination of Schisandrim in Baojing Granule by RP-HPLC
TANG Xiao-xia;CHEN Li;SU Wan-fu
..............page:543-544
zhu she yong mei luo xi lin na zhi guo min xing xiu ke ji ban qiu zhen hou shui zhong 1 li
wang li juan ; wang wei wei ; sui hai shan
..............page:575
Study of Compatible Stability on Salvia Injection and Transfusion
LIN Xiao-ming;HUANG Min;ZHU Jian
..............page:567-570
Establishment and Discussion of the Drug Utility Related Risk Causal Model
LI Chun-xiao;WU Zhi-ang;HU Xin
..............page:549-552,556